Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC). A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer : Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC)

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570291225929560704
  • NII Article ID
    10025132030
  • Data Source
    • CiNii Articles

Report a problem

Back to top